Ongoing studies have indicated that PD-L1 as a receptor could transmit signals and impact the anti-apoptosis, chemotaxis, neoantigen presentation, and glycolysis of tumor cells or APCs (55–59). The gene discussed is CD274; the disease is neoplasm.